A decade after the so-called “Mediator scandal”, a court in Paris announced its final verdict against the Servier Laboratoires and the French National Agency for the Safety of Medicines and Health Products (ANSM).
The court stated that the Mediator drug made by Servier caused the death of 3,000 women from heart failure. The court found the drugmaker guilty of fraud for hiding the side effects of Mediator licensed as a diabetes treatment, while over five million women used it as an appetite suppressant to lose weight.
Servier Laboratoires was fined 2.7 million euros but cleared of its charges for fraud.
Sylvie Daunis, who presided over the ruling, said: “Despite the knowledge they had of the risks incurred for many years, they never took the necessary measures and thus deceived consumers of Mediator.” She added that the company undermined confidence in the French health system.
The company's chairman, Jacques Servier died in 2014 before the opening of the case. Servier's former deputy boss, Jean-Philippe Seta was sentenced to a suspended jail sentence of four years. The court on also fined France's drug regulator ANSM 303,000 euros.
The plaintiffs had sought one billion euros in damages, but the general prosecution gave a cap of 9 million euros, the highest sum they can request in accordance with French law.
Lawyer Jean-Christophe Coubris dismissed the figure, saying the sum can be earned within six hours of work at the giant Servier Laboratoires. Coubris, who specializes in medical malpractice, represented 2,600 plaintiffs including families of dead victims and individuals who were severely damaged by the drug.
The case was opened in the summer of 2019 and ended a year later. The final ruling came after 517 hours of hearings that focused on one fundamental question: How did doctors keep prescribing Mediator for 33 years despite the constant warnings of its risks? The drug was withdrawn from pharmacies in 2009.
